Close Menu
    • Home
    • Contact Us
    Punjab PostPunjab Post
    • Automotive
    • Business
    • Editorial
    • Entertainment
    • Health
    • Luxury
    • Lifestyle
    • News
    • Sports
    • Technology
    • Travel
    Punjab PostPunjab Post
    Home » As COVID-19 cases soar again in China, cremations are rising
    Health

    As COVID-19 cases soar again in China, cremations are rising

    December 22, 2022
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    The Chinese government has already prepared for an inevitable spike in deaths related to COVID-19 following the reversal of Beijing’s “zero-COVID” policy. In response to widespread protests, the government loosened its restrictions, which many in the country believe contributed to the death of ten people in a fire that occurred in a high-rise apartment building.

    As COVID-19 cases soar again in China, cremations are risingAs cases soared, China’s health care system was caught unprepared and scrambling to find beds and medicines to maintain clinics. There have been tens of thousands of fever clinics added to hospitals and even sports arenas in major cities throughout China, including Beijing, Shanghai, Chengdu, and Wenzhou. Asymptomatic cases are no longer reported by officials.

    Experts have already predicted that China could experience more than one million COVID-related deaths next year. According to Our World in Data, a spike occurred in March of this year with a rolling average of 26,570. The current wave peaked at 40,791 cases with a high of 62,439 on Dec. 2. Prior to the rollback of zero-COVID, WHO Emergencies Director Mike Ryan argued that “the control measures in themselves were not stopping the disease.”

    There is a significant lack of vaccinations in China, which contributes to the difficulty. As of December, China was delivering 100,000 to 200,000 doses per day. As of Dec. 13, that number had risen to more than 1.43 million. For years, China refused to adopt vaccines from the West. Instead, it relied on a vaccine called Sinopharm that doesn’t use mRNA models. These introduce antigen templates without exposing people to real viruses. Compared to older vaccine models, the more recent vaccines also scale and produce faster.

    China has approved the Pfizer-BioNTech vaccine for use, with the first batch being sent out Wednesday. There were no details on the size or timing of the delivery. Currently, the vaccine is only available to Germans living in China, but Beijing plans to use it for Chinese nationals as well. The country has around 20,000 Germans. As an exchange, Chinese citizens in Germany can receive SinoVac.

    Related Posts

    New Ebola vaccine enters human trial as Congo cases rise

    August 5, 2026

    Michigan outbreak update confirms two cyclospora deaths

    August 4, 2026

    DR Congo faces its largest recorded Ebola outbreak

    August 3, 2026

    DR Congo Ebola cases rise to 1,307 with 377 deaths

    July 30, 2026

    Congo Ebola cases cross 3,000 following rapid regional spread

    July 27, 2026

    DR Congo Ebola outbreak reaches 2,267 cases and 893 deaths

    July 18, 2026
    Latest News

    New Ebola vaccine enters human trial as Congo cases rise

    August 5, 2026

    NOVA SCOTIA, CANADA / RankWire.AI / – Moderna has launched an early-stage trial of a…

    Fuego volcano eruption puts Guatemala regions on red alert

    August 5, 2026

    GUATEMALA / RankWire.AI / – Guatemala raised the alert to its highest level in three…

    OECD inflation falls to 4.2% and energy price pressures cool

    August 5, 2026

    PARIS / RankWire.AI / – Annual inflation across OECD economies slowed to 4.2% in June…

    © 2026 Punjab Post | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.